| Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 02089-16, 2017 | 111 | 2017 |
| Acute kidney injury in patients treated with vancomycin and piperacillin‐tazobactam: a retrospective cohort analysis WC Rutter, DR Burgess, JC Talbert, DS Burgess Journal of hospital medicine 12 (2), 77-82, 2017 | 78 | 2017 |
| Increasing incidence of multidrug resistance among cystic fibrosis respiratory bacterial isolates WC Rutter, DR Burgess, DS Burgess Microbial drug resistance 23 (1), 51-55, 2017 | 66 | 2017 |
| Nephrotoxicity in patients with or without cystic fibrosis treated with polymyxin B compared to colistin RL Crass, WC Rutter, DR Burgess, CA Martin, DS Burgess Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02329-16, 2017 | 43 | 2017 |
| Influence of β-lactam infusion strategy on acute kidney injury SE Cotner, WC Rutter, DR Burgess, KL Wallace, CA Martin, DS Burgess Antimicrobial agents and chemotherapy 61 (10), 10.1128/aac. 00871-17, 2017 | 39 | 2017 |
| Vancomycin area under the curve dosing and monitoring at an academic medical center: transition strategies and lessons learned ER Gregory, DR Burgess, SE Cotner, JD VanHoose, AH Flannery, ... Journal of pharmacy practice 33 (6), 774-778, 2020 | 21 | 2020 |
| Respiratory muscle paralysis associated with colistin, polymyxin B, and muscle relaxants drugs: a case report T Myint, ME Evans, DR Burgess, RN Greenberg Journal of Investigative Medicine High Impact Case Reports 4 (1 …, 2016 | 21 | 2016 |
| Utilizing Monte Carlo simulations to optimize institutional empiric antipseudomonal therapy SJ Tennant, DR Burgess, JM Rybak, CA Martin, DS Burgess Antibiotics 4 (4), 643-652, 2015 | 16 | 2015 |
| Pharmacokinetic and pharmacodynamic analyses of ceftaroline in adults with cystic fibrosis EB Autry, JM Rybak, NR Leung, BM Gardner, DR Burgess, MI Anstead, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (1 …, 2016 | 15 | 2016 |
| Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients RZ Thompson, CA Martin, DR Burgess, WC Rutter, DS Burgess Journal of Cystic Fibrosis 15 (5), 660-663, 2016 | 14 | 2016 |
| Focusing the lens on the CAMERA concepts: Early combination β-lactam and vancomycin therapy in methicillin-resistant Staphylococcus aureus bacteremia HA Wilsey, DR Burgess, DS Burgess Antimicrobial Agents and Chemotherapy 64 (7), 10.1128/aac. 00360-20, 2020 | 13 | 2020 |
| Amikacin target achievement in adult cystic fibrosis patients utilizing Monte Carlo simulation VD Nolt, KD Pijut, EB Autry, WC Williams, DS Burgess, DR Burgess, ... Pediatric Pulmonology 54 (1), 33-39, 2019 | 13 | 2019 |
| Pharmacist survey: pharmacist perception of vancomycin area under the curve therapeutic drug monitoring ER Gregory, DR Burgess, SE Cotner, JD VanHoose, AH Flannery, ... Journal of Pharmacy Practice 34 (2), 272-278, 2021 | 11 | 2021 |
| Acute kidney injury associated with area under the curve versus trough monitoring of vancomycin in obese patients H D’Amico, KL Wallace, D Burgess, DS Burgess, S Cotner, R Mynatt, N Li, ... Antimicrobial Agents and Chemotherapy 66 (1), e00886-21, 2022 | 8 | 2022 |
| Fever burden in patients with subarachnoid hemorrhage and the increased use of antibiotics CA Magee, MLT Bastin, K Graves, D Burgess, M Nestor, JR Lamm, ... Journal of Stroke and Cerebrovascular Diseases 28 (11), 104313, 2019 | 8 | 2019 |
| 1026. trends in infective endocarditis during the substance use disorder epidemic at an academic medical center CA Martin, DR Burgess, KL Wallace, J Vanhoose, S Cotner, DS Burgess Open Forum Infectious Diseases 5 (Suppl 1), S306, 2018 | 4 | 2018 |
| Impact of an antimicrobial stewardship and emergency department initiated dalbavancin guideline for patients with acute bacterial skin and soft-tissue infections DR Burgess, RA Baum, A Bailey, T Myint, KL Wallace Open Forum Infectious Diseases 4 (Suppl 1), S267, 2017 | 4 | 2017 |
| Mycobacterium abscessus prosthetic valve endocarditis in a patient with Marfan syndrome SJ Tennant, DW Forster, DR Burgess, MA Huaman JMM Case Reports 2 (5), e000084, 2015 | 4 | 2015 |
| The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: a multicenter survey MR Wimmer, LT Schulz, AG Hamel, RJ Schwei, K Fong, DR Burgess, ... Antimicrobial Stewardship & Healthcare Epidemiology 2 (1), e56, 2022 | 3 | 2022 |
| 1804. Impact of Susceptibility Testing Method on Antibiotic Selection for Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia M Bhatt, DR Burgess, KL Wallace, E Gregory, T Myint Open Forum Infectious Diseases 5 (suppl_1), S511-S512, 2018 | 3 | 2018 |
